Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 409

1.

Results of a retrospective database analysis of drug utilization and costs for treatment of chronic hepatitis B virus infection in the northern Netherlands between 2000 and 2006.

Tu HA, Bos JH, Woerdenbag HJ, Visser ST, Wilschut JC, van Assen S, de Jong-van den Berg LT, Postma MJ.

Clin Ther. 2010 Jan;32(1):133-44. doi: 10.1016/j.clinthera.2010.01.015.

PMID:
20171419
[PubMed - indexed for MEDLINE]
2.

Treatment of chronic hepatitis B: case selection and duration of therapy.

Leung N.

J Gastroenterol Hepatol. 2002 Apr;17(4):409-14. Review.

PMID:
11982721
[PubMed - indexed for MEDLINE]
3.

A cost-effectiveness analysis of currently approved treatments for HBeAg-positive chronic hepatitis B.

Spackman DE, Veenstra DL.

Pharmacoeconomics. 2008;26(11):937-49.

PMID:
18850763
[PubMed - indexed for MEDLINE]
4.

Entecavir: a new nucleoside analogue for the treatment of chronic hepatitis B.

Rivkin A.

Drugs Today (Barc). 2007 Apr;43(4):201-20. Review.

PMID:
17460784
[PubMed - indexed for MEDLINE]
5.

Management of chronic hepatitis B.

Wilt TJ, Shamliyan T, Shaukat A, Taylor BC, MacDonald R, Yuan JM, Johnson JR, Tacklind J, Rutks I, Kane RL.

Evid Rep Technol Assess (Full Rep). 2008 Oct;(174):1-671. Review.

PMID:
19408969
[PubMed - indexed for MEDLINE]
Free Article
6.

A randomized, controlled trial of combination therapy for chronic hepatitis B: comparing pegylated interferon-alpha2b and lamivudine with lamivudine alone.

Chan HL, Leung NW, Hui AY, Wong VW, Liew CT, Chim AM, Chan FK, Hung LC, Lee YT, Tam JS, Lam CW, Sung JJ.

Ann Intern Med. 2005 Feb 15;142(4):240-50.

PMID:
15710957
[PubMed - indexed for MEDLINE]
7.

Cost-effectiveness analysis of entecavir versus lamivudine in the first-line treatment of Australian patients with chronic hepatitis B.

Arnold E, Yuan Y, Iloeje U, Cook G.

Appl Health Econ Health Policy. 2008;6(4):231-46. doi: 10.2165/00148365-200806040-00005.

PMID:
19382822
[PubMed - indexed for MEDLINE]
8.

Screening and early treatment of migrants for chronic hepatitis B virus infection is cost-effective.

Veldhuijzen IK, Toy M, Hahné SJ, De Wit GA, Schalm SW, de Man RA, Richardus JH.

Gastroenterology. 2010 Feb;138(2):522-30. doi: 10.1053/j.gastro.2009.10.039. Epub 2009 Oct 29.

PMID:
19879275
[PubMed - indexed for MEDLINE]
9.

Natural course, therapeutic options and economic evaluation of therapies for chronic hepatitis B.

Han SH.

Drugs. 2006;66(14):1831-51. Review.

PMID:
17040114
[PubMed - indexed for MEDLINE]
10.

[Experiences in antiviral treatment of chronic viral hepatitis B and C in Hungary (1998-2004)].

Pár A, Tornai I, Szalay F.

Orv Hetil. 2007 May 6;148(18):819-26. Hungarian.

PMID:
17468063
[PubMed - indexed for MEDLINE]
11.

Treatment of chronic hepatitis B virus infection - Dutch national guidelines.

Buster EH, van Erpecum KJ, Schalm SW, Zaaijer HL, Brouwer JT, Gelderblom HC, de Knegt RJ, Minke Bakker C, Reesink HW, Janssen HL; Netherlands Association of Gastroenterologists and Hepatologists.

Neth J Med. 2008 Jul-Aug;66(7):292-306. Review.

PMID:
18663260
[PubMed - indexed for MEDLINE]
Free Article
12.

Comparison of antiviral effect of lamivudine with interferon-alpha2a versus -alpha2b in children with chronic hepatitis B infection.

Ozgenc F, Dikici B, Targan S, Doganci T, Akman S, Aydogdu S, Yagci RV.

Antivir Ther. 2004 Feb;9(1):23-6.

PMID:
15040533
[PubMed - indexed for MEDLINE]
13.

Evidence for the insufficient evaluation and undertreatment of chronic hepatitis B infection in a predominantly low-income and immigrant population.

Jung CW, Tan J, Tan N, Kuo MN, Ashok A, Eells SJ, Miller LG.

J Gastroenterol Hepatol. 2010 Feb;25(2):369-75. doi: 10.1111/j.1440-1746.2009.06023.x. Epub 2009 Nov 19.

PMID:
19929923
[PubMed - indexed for MEDLINE]
14.

Development of hepatitis B virus resistance for lamivudine in chronic hepatitis B patients co-infected with the human immunodeficiency virus in a Dutch cohort.

Wolters LM, Niesters HG, Hansen BE, van der Ende ME, Kroon FP, Richter C, Brinkman K, Meenhorst PL, de Man RA.

J Clin Virol. 2002 Apr;24(3):173-81.

PMID:
11856618
[PubMed - indexed for MEDLINE]
15.

Management of viral hepatitis B.

Pramoolsinsup C.

J Gastroenterol Hepatol. 2002 Feb;17 Suppl:S125-45. Review.

PMID:
12000599
[PubMed - indexed for MEDLINE]
16.

Cost-effectiveness of peginterferon alpha-2a compared with lamivudine treatment in patients with HBe-antigen-positive chronic hepatitis B in the United Kingdom.

Veenstra DL, Sullivan SD, Dusheiko GM, Jacobs M, Aledort JE, Lewis G, Patel KK.

Eur J Gastroenterol Hepatol. 2007 Aug;19(8):631-8.

PMID:
17625431
[PubMed - indexed for MEDLINE]
17.

Estimating the future health burden of chronic hepatitis B and the impact of therapy in Spain.

Idris BI, Brosa M, Richardus JH, Esteban R, Schalm SW, Buti M.

Eur J Gastroenterol Hepatol. 2008 Apr;20(4):320-6. doi: 10.1097/MEG.0b013e3282f340c8. Review.

PMID:
18334876
[PubMed - indexed for MEDLINE]
18.

Pegylated interferon alfa-2b alone or in combination with lamivudine for HBeAg-positive chronic hepatitis B: a randomised trial.

Janssen HL, van Zonneveld M, Senturk H, Zeuzem S, Akarca US, Cakaloglu Y, Simon C, So TM, Gerken G, de Man RA, Niesters HG, Zondervan P, Hansen B, Schalm SW; HBV 99-01 Study Group; Rotterdam Foundation for Liver Research.

Lancet. 2005 Jan 8-14;365(9454):123-9.

PMID:
15639293
[PubMed - indexed for MEDLINE]
19.

Medication cost information in a computer-based patient record system. Impact on prescribing in a family medicine clinical practice.

Ornstein SM, MacFarlane LL, Jenkins RG, Pan Q, Wager KA.

Arch Fam Med. 1999 Mar-Apr;8(2):118-21.

PMID:
10101981
[PubMed - indexed for MEDLINE]
20.

Chronic hepatitis B treatment: the cost-effectiveness of interferon compared to lamivudine.

Almeida AM, da Silva AL, Cherchiglia ML, Andrade EI, de Oliveira GL, Acurcio Fde A.

Value Health. 2011 Jul-Aug;14(5 Suppl 1):S24-8. doi: 10.1016/j.jval.2011.05.011.

PMID:
21839893
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk